Kewaunee Scientific sets Sept. 9 Q1 FY27 earnings
KEWAUNEE SCIENTIFIC CORP (KEQU) announced that it plans to release its first quarter fiscal year 2027 financial results on Wednesday, September 9, 2026, after the close of trading.
Rhea-AI Filing Summary
KEWAUNEE SCIENTIFIC CORP (KEQU) announced that it plans to release its first quarter fiscal year 2027 financial results on Wednesday, September 9, 2026, after the close of trading. The results will be made available on the company’s website.
Kewaunee Scientific also reiterates its role as a global provider of laboratory, healthcare, and technical furniture, with manufacturing operations in North Carolina, Minnesota, and India, and sales or warehouse partnerships across the United States, Europe, the Middle East, and Asia. The announcement includes standard forward-looking statement cautions referencing risk factors in its Form 10-K for the year ended April 30, 2026.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Earnings release date: September 9, 2026
Fiscal period: First quarter fiscal year 2027
Year founded: 1906
+2 more
5 metrics
Earnings release date
September 9, 2026
Planned release date for first quarter fiscal 2027 financial results, after market close
Fiscal period
First quarter fiscal year 2027
Period for which results will be reported on September 9, 2026
Year founded
1906
Company founding year stated in the business description
Form 10-K year-end
April 30, 2026
Fiscal year-end referenced for the most recent Form 10-K risk factors
Trading symbol
KEQU
Common stock traded on The Nasdaq Global Market
Key Terms
forward-looking statements, Private Securities Litigation Reform Act of 1995, Force Majeure, Risk Factors, +1 more
5 terms
forward-looking statements regulatory
"contains statements that the Company believes to be "forward-looking statements""
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Private Securities Litigation Reform Act of 1995 regulatory
"within the meaning of the Private Securities Litigation Reform Act of 1995"
Force Majeure legal
"natural disasters and other Force Majeure events"
Force majeure is a legal concept that refers to unexpected events beyond anyone’s control, such as natural disasters, war, or severe disruptions, that prevent a party from fulfilling their obligations. It matters to investors because it can delay or cancel agreements, affecting the timing and certainty of financial transactions and obligations. Essentially, it acts as a shield for parties facing unforeseen, uncontrollable problems.
Risk Factors regulatory
"described under the caption “Risk Factors,” in Item 1A of our Annual Report"
Risk factors are elements or conditions that could cause an investment's value to decrease or lead to potential losses. They are like warning signs or obstacles that can affect the success of an investment, making it uncertain or more unpredictable. Recognizing risk factors helps investors understand the possible challenges and make more informed decisions.
Nu Aire acquisition financial
"our ability to realize the benefits anticipated as a result of the Nu Aire acquisition"
FAQ
When will KEQU report first quarter fiscal 2027 results?
Kewaunee Scientific plans to release its first quarter fiscal 2027 financial results on Wednesday, September 9, 2026, after the close of trading. The company states that this information will be available on its website following the release.
Where will Kewaunee Scientific (KEQU) post its Q1 fiscal 2027 earnings information?
Kewaunee Scientific states that its first quarter fiscal 2027 financial results will be available on the company’s website, www.kewaunee.com, after the release on September 9, 2026.
What business does Kewaunee Scientific (KEQU) operate in?
Kewaunee Scientific describes itself as a global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture, including laboratory casework, fume hoods, healthcare storage solutions, epoxy resin work surfaces, sinks, and biological safety cabinets.
Where is Kewaunee Scientific (KEQU) headquartered and where does it manufacture?
Kewaunee Scientific’s corporate headquarters are in Statesville, North Carolina. It operates three manufacturing facilities in Statesville, additional facilities in Plymouth and Long Lake, Minnesota, and a facility in Bangalore, India, along with warehouse and OEM partnerships in Europe and China.
What risks does Kewaunee Scientific (KEQU) highlight in its forward-looking statement disclaimer?
Kewaunee Scientific cites risks such as realizing benefits from the Nu Aire acquisition, competitive and economic conditions, supply disruptions, changes in customer demand, international risks including currency fluctuations, raw material cost changes, and Force Majeure events, referencing detailed “Risk Factors” in its Form 10-K for the year ended April 30, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 25, 2026
Kewaunee Scientific Corporation
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (704 ) 873-7202
N/A
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. ☐
Item 8.01 Other Events
On August 25, 2026, Kewaunee Scientific Corporation announced that the Company plans to release its first quarter fiscal 2027 earnings on September 9, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. | Description | |||||||
| 99.1 | Press Release of Kewaunee Scientific Corporation dated August 25, 2026. | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| KEWAUNEE SCIENTIFIC CORPORATION (Registrant) | |||||||||||
| Date: August 25, 2026 | By | /s/ Donald T. Gardner III | |||||||||
| Donald T. Gardner III | |||||||||||
| Vice President, Finance | |||||||||||
| Chief Financial Officer | |||||||||||
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027
Exchange: NASDAQ (KEQU) Contact: Donald T. Gardner III
704/871-3274
STATESVILLE, N.C. August 25, 2026 – PRNewswire / Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its first quarter fiscal year 2027 financial results on Wednesday, September 9, 2026 after the close of trading. This information will be available on the Company’s website www.kewaunee.com after the release.
About Kewaunee Scientific
Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company’s portfolio includes laboratory casework, fume hoods, adaptable modular systems, healthcare storage solutions, epoxy resin work surfaces and sinks, biological safety cabinets, and other critical containment lab furniture solutions.
The Company’s corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, Spain, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. The Company also operates manufacturing facilities in Plymouth and Long Lake, Minnesota, and maintains warehouse partnerships in the Netherlands and OEM partnerships in China through its acquisition of Nu Aire, Inc., supporting customers around the world.
Learn more at at http://www.kewaunee.com.
This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers’ required delivery schedules; risks related to fluctuations in the Company’s operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force
CORPORATE OFFICES ● P. O. BOX 1842, STATESVILLE, NORTH CAROLINA 28687-1842 ● 2700 WEST FRONT STREET, STATESVILLE, NORTH CAROLINA 28677-2927
PHONE 704-873-7202 ● FAX 704-873-1275
Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders’ interest. Many important factors that could cause such a difference are described under the caption “Risk Factors,” in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2026, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.